ReviewAmerican journal of translational research2023

Combinational use of trabectedin and pegylated liposomal doxorubicin for recurrent ovarian cancer: a meta-analysis of phase III randomized controlled trials.

Chao Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.